TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E31.71 EPS (ttm)18.80 Insider Own0.10% Shs Outstand392.00M Perf Week0.62%
Market Cap229.39B Forward P/E24.20 EPS next Y24.63 Insider Trans-29.84% Shs Float390.31M Perf Month11.02%
Income7.44B PEG3.06 EPS next Q4.83 Inst Own90.60% Short Float0.68% Perf Quarter7.47%
Sales42.82B P/S5.36 EPS this Y21.80% Inst Trans-0.57% Short Ratio2.06 Perf Half Y7.07%
Book/sh107.89 P/B5.52 EPS next Y7.08% ROA8.50% Target Price662.93 Perf Year7.14%
Cash/sh- P/C- EPS next 5Y10.37% ROE18.30% 52W Range497.83 - 672.34 Perf YTD-10.67%
Dividend1.20 P/FCF38.81 EPS past 5Y30.70% ROI10.80% 52W High-11.83% Beta0.83
Dividend %0.20% Quick Ratio1.10 Sales past 5Y16.50% Gross Margin46.60% 52W Low19.08% ATR12.76
Employees130000 Current Ratio1.60 Sales Q/Q18.30% Oper. Margin20.70% RSI (14)57.74 Volatility1.29% 2.07%
OptionableYes Debt/Eq0.72 EPS Q/Q-8.50% Profit Margin17.40% Rel Volume0.43 Prev Close596.04
ShortableYes LT Debt/Eq0.69 EarningsJul 28 BMO Payout5.70% Avg Volume1.29M Price592.81
Recom1.90 SMA200.86% SMA506.70% SMA2002.16% Volume358,248 Change-0.54%
Apr-25-22Downgrade Wells Fargo Equal Weight → Underweight $525
Jan-26-22Resumed Barclays Overweight $700
Oct-20-21Upgrade Citigroup Neutral → Buy $620 → $700
Oct-15-21Resumed Cowen Outperform $655 → $696
Aug-05-21Resumed Credit Suisse Outperform $580
Jul-16-21Initiated The Benchmark Company Buy $580
Mar-18-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21Initiated Barclays Overweight $525
Jan-08-21Upgrade Credit Suisse Neutral → Outperform $490 → $556
Dec-16-20Downgrade Citigroup Buy → Neutral $550 → $500
Dec-02-20Initiated Goldman Buy $570
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $550
Sep-30-20Initiated Atlantic Equities Overweight $494
Sep-14-20Initiated Morgan Stanley Overweight $485
Aug-20-20Resumed JP Morgan Overweight $460
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jul-07-20Reiterated Needham Buy $383 → $415
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
Aug-18-22 10:39AM  
10:23AM  
Aug-16-22 12:36PM  
12:26PM  
09:00AM  
Aug-15-22 10:00AM  
09:01AM  
Aug-14-22 02:12AM  
Aug-09-22 06:16PM  
Aug-08-22 07:40AM  
Aug-04-22 04:30PM  
09:00AM  
Aug-03-22 08:00AM  
Aug-02-22 08:30AM  
Aug-01-22 02:58PM  
Jul-29-22 10:37AM  
Jul-28-22 02:00PM  
10:44AM  
08:53AM  
07:49AM  
07:39AM  
07:25AM  
06:00AM  
Jul-27-22 12:05PM  
11:02AM  
08:23AM  
01:38AM  
Jul-26-22 10:01AM  
Jul-25-22 09:00AM  
Jul-22-22 07:30AM  
Jul-21-22 06:22PM  
12:10PM  
Jul-20-22 06:00PM  
12:59PM  
Jul-18-22 10:18AM  
09:04AM  
08:15AM  
Jul-15-22 02:39PM  
Jul-14-22 06:00PM  
Jul-13-22 12:18PM  
09:10AM  
Jul-11-22 11:23AM  
Jul-08-22 05:49PM  
Jul-07-22 06:00PM  
04:30PM  
11:27AM  
10:15AM  
Jul-06-22 07:02AM  
05:38AM  
Jul-05-22 09:00AM  
Jul-04-22 07:19AM  
Jul-01-22 07:47AM  
Jun-30-22 06:00PM  
Jun-27-22 10:44AM  
Jun-24-22 05:50PM  
Jun-23-22 01:11PM  
Jun-22-22 06:00PM  
10:29AM  
Jun-20-22 12:28PM  
Jun-16-22 05:50PM  
09:33AM  
Jun-14-22 06:00PM  
11:45AM  
10:07AM  
Jun-13-22 03:40PM  
09:51AM  
07:11AM  
Jun-10-22 01:27PM  
08:56AM  
Jun-09-22 09:58AM  
Jun-07-22 05:50PM  
Jun-06-22 06:00PM  
08:00AM  
Jun-03-22 11:31AM  
Jun-02-22 08:00AM  
Jun-01-22 09:58AM  
09:21AM  
May-30-22 02:09PM  
May-24-22 11:00AM  
May-23-22 10:32AM  
May-19-22 02:16PM  
09:00AM  
May-17-22 02:52PM  
May-13-22 11:06AM  
07:20AM  
May-06-22 08:00AM  
May-05-22 11:55AM  
08:15AM  
08:05AM  
May-04-22 05:31PM  
11:47AM  
Apr-28-22 03:00PM  
12:14PM  
12:08PM  
11:17AM  
09:16AM  
07:15AM  
07:07AM  
06:00AM  
05:55AM  
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williamson StephenSr. VP and CFOAug 15Option Exercise157.6812,3001,939,46456,244Aug 16 05:25 PM
Williamson StephenSr. VP and CFOAug 15Sale603.4812,3007,422,78943,944Aug 16 05:25 PM
Williamson StephenSr. VP and CFOAug 12Option Exercise157.6815,0002,365,20058,944Aug 16 05:25 PM
Williamson StephenSr. VP and CFOAug 12Sale601.3215,0009,019,81343,944Aug 16 05:25 PM
Boxer Michael ASVP and General CounselAug 08Option Exercise192.987,2831,405,47319,681Aug 10 04:08 PM
Boxer Michael ASVP and General CounselAug 08Sale590.807,2834,302,79612,398Aug 10 04:08 PM
CASPER MARC NChairman & CEOAug 04Option Exercise129.7710,0001,297,700193,373Aug 05 04:10 PM
CASPER MARC NChairman & CEOAug 04Sale589.7610,0005,897,621183,373Aug 05 04:10 PM
CASPER MARC NChairman & CEOAug 03Option Exercise129.7710,0001,297,700193,373Aug 05 04:10 PM
CASPER MARC NChairman & CEOAug 03Sale588.2810,0005,882,769183,373Aug 05 04:10 PM
CASPER MARC NChairman & CEOAug 02Option Exercise129.7710,0001,297,700193,373Aug 03 04:33 PM
CASPER MARC NChairman & CEOAug 02Sale588.3610,0005,883,584183,373Aug 03 04:33 PM
CASPER MARC NChairman & CEOAug 01Option Exercise129.7710,0001,297,700193,373Aug 03 04:33 PM
CASPER MARC NChairman & CEOAug 01Sale592.5210,0005,925,218183,373Aug 03 04:33 PM
MANZI JIM PDirectorAug 01Sale597.24814486,15615,807Aug 03 04:09 PM
Lagarde MichelExecutive Vice President & COOMay 27Option Exercise354.2013,0304,615,23728,788May 31 05:13 PM
Lagarde MichelExecutive Vice President & COOMay 27Sale565.0413,0307,362,49315,758May 31 05:13 PM
Lagarde MichelExecutive Vice President & COOMay 26Option Exercise238.3616,7643,995,90632,522May 31 05:13 PM
Lagarde MichelExecutive Vice President & COOMay 26Sale536.0116,7648,985,59315,758May 31 05:13 PM
Lagarde MichelExecutive Vice President & COOMay 25Option Exercise238.115,0481,201,97520,806May 25 07:54 PM
Lagarde MichelExecutive Vice President & COOMay 25Sale542.475,0482,738,37015,758May 25 07:54 PM
Lagarde MichelExecutive Vice President & COOMay 24Option Exercise204.1617,1503,501,33632,908May 25 07:54 PM
Lagarde MichelExecutive Vice President & COOMay 24Sale548.3017,1509,403,38315,758May 25 07:54 PM
CASPER MARC NChairman & CEOMay 04Option Exercise129.7710,0001,297,700193,373May 05 06:09 PM
CASPER MARC NChairman & CEOMay 04Sale562.462,1811,226,730183,373May 05 06:10 PM
CASPER MARC NChairman & CEOMay 04Sale548.277,8194,286,905185,554May 05 06:09 PM
CASPER MARC NChairman & CEOMay 03Option Exercise129.7710,0001,297,700193,373May 05 06:09 PM
CASPER MARC NChairman & CEOMay 03Sale547.6110,0005,476,103183,373May 05 06:09 PM
CASPER MARC NChairman & CEOMay 02Option Exercise129.7710,0001,297,700193,373May 04 05:35 PM
Spar Debora LDirectorMay 02Sale544.36200108,872810May 04 05:45 PM
CASPER MARC NChairman & CEOMay 02Sale545.6010,0005,456,029183,373May 04 05:35 PM
Lagarde MichelExecutive Vice President & COOMar 01Sale541.296,1003,301,89015,878Mar 02 04:17 PM
MANZI JIM PDirectorFeb 14Sale563.951,500845,92516,252Feb 15 08:24 PM
Stevenson MarkExecutive Vice President & COODec 01Option Exercise175.4626,9254,724,37486,181Dec 03 04:16 PM
Stevenson MarkExecutive Vice President & COODec 01Sale631.8826,92517,013,31059,256Dec 03 04:16 PM
Stevenson MarkExecutive Vice President & COONov 02Option Exercise175.4626,9254,724,37486,181Nov 03 04:36 PM
Williamson StephenSr. VP and CFONov 02Option Exercise129.7722,5502,926,31462,771Nov 03 04:34 PM
Williamson StephenSr. VP and CFONov 02Sale638.1022,55014,389,04540,221Nov 03 04:34 PM
Stevenson MarkExecutive Vice President & COONov 02Sale638.0326,92517,179,05459,256Nov 03 04:36 PM
Stevenson MarkExecutive Vice President & COONov 01Option Exercise175.4626,9254,724,37486,181Nov 03 04:36 PM
Stevenson MarkExecutive Vice President & COONov 01Sale632.6926,92517,035,09359,256Nov 03 04:36 PM